查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1392005

颈椎病治疗市场：依治疗类型、给药途径、配销通路及地区

Cervical Spondylosis Treatment Market, By Type of Treatment (Medications and Surgery), By Route of Administration, By Distribution Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年全球颈椎病治疗市场规模为54亿美元，预计2022年至2030年复合年增长率为5.6%，2030年达79亿美元。

报告范围 报告详情
基准年 2022年 2023年市场规模 54亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期复合年增长率 5.60% 2030年市场规模预测 79亿美元
图 1. 2023 年按地区分類的颈椎病治疗全球市场占有率（%）
颈椎病治疗市场-IMG1

颈椎病是一种影响颈部的退化性疾病。颈椎（颈部）与老龄化相关的磨损的总称，可导致颈部疼痛、颈部僵硬和其他症状。它也被称为关节炎或颈椎骨关节炎。这是颈部软骨、椎间盘、韧带和骨骼的自然磨损。这种情况很常见，并且随着老龄化而恶化。在许多情况下，不需要特殊治疗。如果出现症状，治疗可能包括药物、皮质类固醇注射、物理治疗，有时还包括手术。

市场动态：

颈椎病负担的增加、颈背痛盛行率的上升、老年人口的增加以及全球对安全有效颈椎病治疗的需求不断增加正在推动全球颈椎病治疗市场的成长。

例如，颈椎病变是老年人脊髓型颈椎病变的一个非常常见的原因。它是老年人中最常见的脊椎功能障碍。这种情况很常见，并且随着老龄化而恶化。 60岁以上的老年人中，85%以上有颈椎病。因此，随着老年人口的增加和颈椎病负担的加重，对安全有效的颈椎病治疗的需求也越来越大。据世界卫生组织（WHO）称，到2030年，世界上六分之一的人将超过60岁，到2050年，世界60岁以上的人口将增加一倍（达到21亿人）。 。

本研究的主要特点

  • 本报告对全球颈椎病治疗市场进行了详细分析，并列出了以2022年为基准年的预测期（2023-2030年）的市场规模和復合年增长率。
  • 它还强调了各个细分市场的潜在收益成长机会，并为该市场说明了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据以下参数（例如公司亮点、产品系列、主要亮点、财务实绩和策略）介绍了全球颈椎病治疗市场的主要企业。
  • 本研究涵盖的主要企业包括辉瑞公司、雅培实验室、阿斯特捷利康公司、诺华公司、默克公司、梯瓦製药工业有限公司、安进公司、百时美施贵宝公司、礼来公司、葛兰素史克公司、Johnson &Johnson Services, Inc.、Sanofi SA、Stryker Corporation、Zimmer Biomet Holdings, Inc. 和 Medtronic plc。
  • 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出资讯的决策。
  • 本研究报告针对该产业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员可以透过用于分析全球颈椎病治疗市场的各种策略矩阵来促进他们的决策。

目录：

第一章 研究目的与假设

  • 研究目标
  • 假设
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

  • 市场动态
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 併购场景

第四章颈椎病变治疗市场-冠状病毒（COVID-19）大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第五章颈椎病治疗市场，依治疗类型，2018-2030

  • 介绍
  • 剂量
  • 非类固醇消炎剂(NSAID)
  • 皮质类固醇
  • 肌肉鬆弛剂
  • 抗忧郁症
  • 其他的
  • 外科手术

第六章颈椎病变治疗市场，依给药途径，2018-2030

  • 介绍
  • 口服
  • 注射
  • 局部的
  • 其他的

第七章颈椎病治疗市场，依配销通路，2018-2030

  • 介绍
  • 医院药房
  • 零售药房
  • 线上药房

第八章 2018-2030年颈椎病治疗市场（分地区）

  • 介绍
  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 欧洲其他地区
  • 亚太地区
  • 中国
  • 日本
  • 印度
  • 东南亚国协
  • 澳洲
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章竞争形势

  • Pfizer Inc.
  • Abbott Laboratories
  • AstraZeneca Plc.
  • Novartis AG
  • Merck & Co. Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • Sanofi SA
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Medtronic plc

第10章

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI5710

The global cervical spondylosis treatment market size was valued at US$ 5.4 Billion in 2023 and is expected to reach US$ 7.9 Billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 5.6% from 2022 to 2030.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 5.4 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 5.60% 2030 Value Projection: US$ 7.9 Bn
Figure 1. Global Cervical Spondylosis Treatment Market Share (%), By Region, 2023
Cervical Spondylosis Treatment Market - IMG1

Cervical spondylosis is a type of degenerative disease that affects the neck. It is a general term for age-related wear and tear in the cervical spine (neck) that can lead to neck pain, neck stiffness, and other symptoms. Sometimes this condition is called arthritis or osteoarthritis of the neck. It is the natural wearing down of cartilage, disks, ligaments, and bones in the neck. It is very common and worsens with age. In many cases, no specific treatment is required. If symptoms occur, treatments include medication, corticosteroid injections, physiotherapy, and sometimes surgery.

Market Dynamics:

Rising burden of cervical spondylosis, increasing prevalence of neck and back pain, growing geriatric population, and the growing demand for safe & effective cervical spondylosis treatment around the globe are expected to propel the growth of the global cervical spondylosis treatment market.

For instance, cervical spondylosis is a very common cause of myelopathy in the elderly. It is the most common spine dysfunction in elderly people. It is very common and worsens with age. More than 85% of people older than the age of 60 are affected by cervical spondylosis. Thus, with the growing geriatric population and the rising burden of cervical spondylosis, the demand for safe and effective cervical spondylosis treatment is also increasing. As per the World Health Organization (WHO), by 2030, one in six people in the world will be aged 60 years or over, and the world's population of people aged 60 years and older will double (2.1 billion) by 2050.

Key Features of the Study:

  • This report provides an in-depth analysis of the global cervical spondylosis treatment market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global cervical spondylosis treatment market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
  • The key companies covered as a part of this study include Pfizer Inc., Abbott Laboratories, AstraZeneca Plc., Novartis AG, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., Amgen Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Sanofi S.A., Stryker Corporation, Zimmer Biomet Holdings, Inc., and Medtronic plc
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global cervical spondylosis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cervical spondylosis treatment market

Detailed Segmentation:

  • By Type of Treatment:
    • Medication
    • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
    • Corticosteroids
    • Muscle relaxants
    • Antidepressants
    • Others (Anti-seizure medications, etc.)
    • Surgery
  • By Route of Administration:
    • Oral
    • Injection
    • Topical
    • Others (patches, etc.)
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Pfizer Inc.
    • Abbott Laboratories
    • AstraZeneca Plc.
    • Novartis AG
    • Merck & Co. Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Amgen Inc.
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • GlaxoSmithKline plc
    • Johnson & Johnson Services, Inc.
    • Sanofi S.A.
    • Stryker Corporation
    • Zimmer Biomet Holdings, Inc.
    • Medtronic plc

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Cervical Spondylosis Treatment Market, By Type of Treatment
    • Global Cervical Spondylosis Treatment Market, By Route of Administration
    • Global Cervical Spondylosis Treatment Market, By Distribution Channel
    • Global Cervical Spondylosis Treatment Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Cervical Spondylosis Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Cervical Spondylosis Treatment Market, By Type of Treatment, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Medication
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  • Corticosteroids
  • Muscle relaxants
  • Antidepressants
  • Others
  • Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Cervical Spondylosis Treatment Market, By Route of Administration, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Injection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Cervical Spondylosis Treatment Market, By Distribution Channel, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Cervical Spondylosis Treatment Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbott Laboratories
  • AstraZeneca Plc.
  • Novartis AG
  • Merck & Co. Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • Sanofi S.A.
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Medtronic plc

10. Section

  • Research Methodology
  • About us